Financial Performance - Q2 2024 GAAP revenue increased by 6.5% to 1,451.5millioncomparedtoQ22023[2][3]−AdjustedrevenueforQ22024alsogrewby6.51,452.4 million [2][3] - GAAP operating income margin improved to 22.6% in Q2 2024, up 140 basis points from Q2 2023 [2][3] - Adjusted consolidated EBITDA margin reached 38.5% in Q2 2024, a 170 basis point increase [2][3] - GAAP net income attributable to SS&C surged 45.6% to 190.3millioninQ22024[2][3]ShareRepurchaseandCapitalAllocation−Thecompanyrepurchased3.7millionsharesfor227.0 million in Q2 2024, marking the highest quarterly buyback in its history [3] - SS&C announced a new 1billioncommonstockrepurchaseprogram,renewingitscapitalallocationstrategy[10]−Therepurchaseprogramallowsforopenmarketpurchases,privatelynegotiatedtransactions,andRule10b5−1plans[11]OperationalHighlights−Adjustedorganicrevenuegrowthwas6.4565.4 million in operating cash flow for the first six months of 2024, a 3.2% decrease from the same period in 2023 [9] - SS&C ended Q2 2024 with 462.7millionincashandcashequivalentsand6,653.1 million in gross debt [9] Guidance and Future Outlook - For Q3 2024, the company expects adjusted revenue between 1,420.0millionand1,460.0 million [12] - Full-year 2024 guidance projects adjusted revenue in the range of 5,706.2millionto5,866.2 million [12] - Adjusted diluted earnings per share for FY 2024 are forecasted between 4.98and5.22 [12] Industry and Market Position - SS&C serves approximately 20,000 financial services and healthcare organizations globally, ranging from large corporations to small and mid-market firms [15] - The company's software-enabled services revenue reached $1,192.4 million in Q2 2024, representing the majority of total revenue [16] - SS&C maintains a strong position in the financial services software market, with recurring revenue growth indicating stable demand [3]